A St. Louis jury has reached a multi-billion-dollar verdict in a talc ovarian cancer lawsuit while simultaneously finding that it was asbestos in that talc that led to the onset of the plaintiffs’ cancer.
The verdict impacted the trading price of the world’s largest health care goods manufacturer, sending the stock down almost a full percentage point in the aftermath. The 22 plaintiffs in the case were ...
continue reading...